News & Events
Read the latest news from the Northwestern University Feinberg School of Medicine’s Center for Information Partnerships. The links below take you to articles where you can learn more about our institute's latest events and accomplishments.
Dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, reduced the risk of cardiovascular-related morality and hospitalization in patients with heart failure, regardless of ejection fraction, according to a series of clinical trial reports.
Learn more about MD-PhD Student and Doctoral Research Assistant Yuyang Yang.
Northwestern basic scientists are leveraging artificial intelligence and machine learning to untangle complex intracellular processes.
Metformin, a common, safe and inexpensive drug for type 2 diabetes, lowered the odds of emergency department visits, hospitalizations or death due to COVID-19 by over 40 percent, according to a new multi-site clinical trial.
- 07.27.2022I.AIM Solutions Engineer Bill Temps and colleagues discuss the potential to improve vaccine access.
Learn more about Postdoctoral Scholar Xiaotao Wang.
- Second Annual Third Coast Augmented Intelligence for Health Bowl (3C-AI4H) Now Accepting Applications06.29.2022
Applications are now open for the second annual Third Coast Augmented Intelligence for Health Bowl (3C-AI4H).
Proteins gain new interactions that are potentially oncogenic and could drive cancer development and growth, according to a recent study.
HeartShare is excited to welcome the inaugural cohort of the HeartShare Research Skills Training Program.
A deep learning model has discovered genetic variations in cancer that are undetectable in traditional genome sequencing.
- 06.01.2022Rohail Memon, second year medical student, works with I.AIM Lead Clinical Data Scientist Beatrice Nardone, MD, PhD.
Joyce and Ed Wu, MD, support I.AIM's Health Data Gymnasium.
David Hsi is a sophomore at Northwestern University studying Data Science and Business Institutions. He has a strong interest in the power of data science and statistics and their real-world implications in everyday life. In the future, he hopes to go into the sports analytics field or the tech industry as a data scientist.
- 04.15.2022Organized by Lee Cooper, Director of the I.AIM Center for Computational Imaging & Signal Analytics in Medicine, and colleagues
- 03.24.2022Bringing fetal ultrasound to developing countries by combining AI, low-cost hand-held ultrasound devices, and a smartphone.
Gigi is the first I.AIM Clinical Informatics Fellow. Her passions are wide-ranging, from caring for diabetic patients and innovating in informatics, to exploring and taking selfies with dogs.
Of the estimated five million patients in the U.S. diagnosed with heart failure annually, nearly half will have heart failure with preserved ejection fraction (HFpEF) and at the forefront of HFpEF research are Feinberg investigators.
- 03.16.2022The team developed an electronic health record (EHR) integrated natural language processing (NLP) system to automatically identify radiographic findings requiring follow-up.
Shifting machine learning workflows to a proactive model could speed data collection and analysis, according to a viewpoint published in JAMA.
- 02.25.2022I.AIM Chief Ethics Officer Kelly N. Michelson, MD, MPH, published a viewpoint in JAMA.
A genetic mutation changing just one base pair of nucleotides greatly increases risk of a lethal subtype of childhood acute lymphoblastic leukemia, according to a recent study.
- 01.20.2022With support from a recent National Institutes of Health U01 grant, principal investigator Yuan Luo, PhD looks to further integrate artificial intelligence with clinical medical practice.
The medical school has begun introducing a new component of the medical education curriculum: instruction in Digital Health and Data Science for medical students.
Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved heart failure-related symptoms and physical limitations in patients with heart failure with preserved ejection fraction.
A machine learning model can identify patients at risk of a rare cardiomyopathy, according to a recent study.